This study is to investigate the clinical characteristics of late pregnancy with asymptomatic 2019 novel coronavirus disease (COVID-19) infection, evaluate the outcome of maternal and fetal prognosis, and identify the evidence of intrauterine vertical transmission. A 22-years-old pregnant woman with asymptomatic COVID-19 infection who was admitted to our hospital on 11 February 2020 was enrolled in this study. Clinical data including laboratory test results and chest computed tomography (CT) scanning were collected and reviewed. Diagnosis of late pregnancy with asymptomatic COVID-19 infection was made. Lumbar anesthesia for cesarean section was performed and a female baby was delivered uneventfully, with the Apgar score of 9 to 10 points. Three times of COVID-19 nucleic acid test for the baby was negative after delivery. The puerpera returned to normal after the operation and two times of throat swab COVID-19 nucleic acid test were all negative after antiviral therapy. We reported an asymptomatic COVID-19 pregnant woman with detailed clinical information and our result indicated that for late pregnant women with asymptomatic COVID-19 infection, there might be no intrauterine infection caused by vertical transmission. K E Y W O R D Sasymptomatic COVID-19 infection, intrauterine infection, late pregnancy, vertical transmission
As a nuclear transcription factor, cAMP response element-binding protein (CREB) can be used in gene transcription regulation, apoptosis regulation, immune response and other life activities. However, the biological characteristics of CREB are controlled by its phosphorylation level. The surface of gold electrode is modified by DNA sequence of capture probe containing specific and high affinity binding sites of CREB. Then, the methylene blue (MB) solution is added into the gold nanoparticle/DNA complex. The composite nanomaterials, namely gold nanoparticles/DNA/MB, are obtained by inserting MB into DNA molecules. The nanomaterials are used as signal markers, and the phosphorylation sites are specifically labeled by Zr4+-mediated nanocomposite beacons. It is used to detect the phosphorylation level of CREB in placenta of preeclampsia pregnant women. In the experiment, the phosphorylated CREB can be fully modified on the surface of gold nanoprobe electrode after incubating for 130 min. The optimal incubation time between nanocomposite beacon and targeted protein electrode is 60 min. Based on this method, the development trend of CREB phosphorylation level is obtained. Comparing the phosphorylation level of CREB in preeclampsia pregnant women and normal pregnant women, it can be seen that the phosphorylation level of CREB in preeclampsia pregnant women is significantly increased. The designed nanocomposites have good sensitivity and specificity for the phosphorylation level of CREB, which can help to analyze and study the protein phosphorylation level of patients under physiological and pathological conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.